Cisplatin nephrotoxicity and protection by silibinin

Area of Science:

• Nephrology
• Pharmacology
• Toxicology

Background:

• Cisplatin, an anticancer drug, causes nephrotoxicity affecting various kidney segments.
• Silibinin, a flavonoid, has shown hepatoprotective properties in prior studies.
• This research investigates silibinin's potential to mitigate cisplatin-induced renal dysfunction.

Purpose of the Study:

• To evaluate the nephroprotective effects of silibinin against cisplatin-induced renal damage.
• To assess silibinin's impact on glomerular and tubular function and morphology.
• To determine if silibinin can prevent or reduce cisplatin-induced kidney injury.

Main Methods:

• Rat model induced with cisplatin (5 mg/kg) to cause renal damage.
• Silibinin (200 mg/kg, i.v.) administered 1 hour prior to cisplatin.
• Kidney function monitored via urinary markers; tubular morphology assessed via light microscopy.

Main Results:

• Cisplatin induced rapid kidney dysfunction, including decreased creatinine clearance and increased proteinuria.
• Silibinin pretreatment completely prevented cisplatin's effects on creatinine clearance and proteinuria.
• Silibinin ameliorated proximal tubular damage and reduced urinary enzyme activity and magnesium wasting.

Conclusions:

• Silibinin demonstrated significant nephroprotective effects against cisplatin-induced glomerular and tubular damage.
• Silibinin effectively ameliorated both functional and morphological alterations in the kidney.
• Silibinin shows promise as a nephroprotectant for clinical application in patients receiving cisplatin.